Militants capture 28 Pak soldiers in Waziristan

Sahil Nagpal 7 October 2007

Peshawar, Oct 7 : Pro-Taliban militants kidnapped 28 paramilitary soldiers in the troubled North Waziristan tribal region.

Ranbaxy Labs is good investment at current levels

Shalini Kakkad 7 October 2007

As per views of Technical Analysts, Ranbaxy Labs is looking very fairly valued at current market price. The stock ended at 433.10 levels on Friday, down by Rs 9.20 or 2.08%.

Karnataka crisis: BJP to submit support withdrawal letter to Governor today

Sahil Nagpal 7 October 2007

Bangalore, Oct 7 : The Bharatiya Janata Party (BJP) will today meet Karnataka Governor Rameshwar Thakur to submit the letter of withdrawal of support to the H D Kumaraswamy Government.

Blue Line bus crushes 8 persons to death in Delhi

Sahil Nagpal 7 October 2007

New Delhi, Oct 7 : At least eight persons, including women and children, were crushed to death in Badarpur area of West Delhi when a Blue Line bus rammed into a bus stand on Sunday morning.

Musharraf wants national reconciliation

Sahil Nagpal 7 October 2007

Diana’s death fears were fuelled by psychics

Sahil Nagpal 7 October 2007

London, Oct 7 : Princess Diana's fears that there was a plot to kill her stemmed from warnings from psychics, it has been claimed.

Pages

News in Focus

Tata Consultancy Services (TCS) Share Price Target at Rs 3,900: Sharekhan Research
Tata Consultancy Services (TCS) Share Price Target at Rs 3,900: Sharekhan Research
Featured, Analyst View, India, Sharekhan, TCS, Technology Sector

In its latest research update, Mirae Asset Sharekhan maintains a BUY recommendation on Tata Consultancy Services (TCS), India’s IT bellwether, despite a challenging quarter marked by subdued revenu

Glenmark Pharmaceuticals Share Price Target at Rs 2,430: Motilal Oswal Research
Glenmark Pharmaceuticals Share Price Target at Rs 2,430: Motilal Oswal Research
Featured, Analyst View, Glenmark Pharmaceuticals, India, Motilal Oswal, Pharmaceutical Sector

Motilal Oswal has reiterated its BUY rating on Glenmark Pharmaceuticals, setting a compelling price target of Rs 2,430—implying a robust 28% upside from current levels.

Exness Registrations Ban on Indian Users; Detailed Review and Implication of Forex Trading on Non-FIU Complaint Platforms
Exness Registrations Ban on Indian Users; Detailed Review and Implication of Forex Trading on Non-FIU Complaint Platforms
Featured, Exness, India, OctaFX

Exness has stopped new memberships in India and there isn't any clarification from the company regarding this change.

How Typography Enhances Readability and Visual Appeal in Posters
How Typography Enhances Readability and Visual Appeal in Posters
Featured, Technology News

Typography is one of the most crucial elements of poster design.

SBI Life Share Price Jumps 1.37 Percent; Immediate Resistance at Rs 1,862
SBI Life Share Price Jumps 1.37 Percent; Immediate Resistance at Rs 1,862
Featured, Stock Markets, Banking Sector, India, SBI Life Insurance

SBI Life Share price jumped 1.37 percent on Friday and the stock is currently looking bullish on technical charts. We could face minor resistance in range of Rs 1,860 - 1,875.

Crompton Greaves Consumer Share Price Target at Rs 410: Kotak Securities
Crompton Greaves Consumer Share Price Target at Rs 410: Kotak Securities
Featured, Analyst View, Stock Markets, Crompton Greaves, Electronics Sector, India, Kotak Securities

Kotak Institutional Equities has issued a resounding BUY call on Crompton Greaves Consumer, setting a fair value target of Rs 410 against the current market price of Rs 344.